Introduction Patients with chronic obstructive pulmonary disease (COPD) have impaired balance and hence fall more frequently. Easy application of balance evaluation tests can prevent the loss of time in the outpatient clinic for patients with COPD. In this study, we aimed to compare the efficacy of Berg Balance Scale (BBS), a time‐consuming but a widely used test, with other easy‐to‐perform tests such as the Single Leg Stance (SLS), Five Repetition Sit to Stand (5STS), Four Step Square (FSST), and Timed Up and Go (TUG) tests. Methods A total of 71 patients with COPD and 70 control subjects with matching demographic characteristics were included in the study. All patients undertook pulmonary function tests and their scores of 6‐min walk‐test (6MWT), modified Medical Research Council (mMRC) dyspnea scale, COPD assessment questionnaire (CAT), and body mass index (B) were recorded. In addition, the severity of airway obstruction (O), the dyspnea severity (D), and exercise capacity (E) (BODE) index scores were measured. All patients with COPD were classified into 4 groups, A to D, based on the GOLD 2017 criteria. All subjects undertook the BBS, SLS, 5STS, FSST and TUG tests. Results Balance tests revealed increased balance impairment in patients with COPD in comparison with the control subjects (P < 0.05). The BBS, SLS, FSST, and TUG examinations suggested that balance impairment was frequent in Groups C and D patients with COPD (P < 0.05). FSST and TUG had the highest correlation with BBS (r = −0.812 and −0.842 and P <0.001 and <0.001, respectively). The results of FSST and TUG were the closest to those of BBS test. Conclusions FSST and TUG tests can be applied for the assessment of bodily balance status among patients with COPD in outpatient clinics.
Objectives: We aimed to compare right and left ventricular functions by echocardiography (ECHO) according to chronic obstructive pulmonary disease (COPD) groups, and to determine their associations with functional parameters. Methods: Data of patients with COPD who underwent ECHO between 2015 and 2018 were analyzed retrospectively. The results of pulmonary function tests, 6-minute-walking test (6MWT), Modified Medical Research Council (mMRC), COPD assessment test (CAT), and BODE scores were recorded together with ECHO results showing right and left ventricular functions. Results: 126 COPD patients were evaluated. Of these, 37.3% was in group A, 28.6% in group B, 12.7% in group C, and 21.4% in group D. Most common comorbidities were cardiovascular diseases (CVD) and pulmonary hypertension (PH); these were most frequently seen in groups D and B. Regarding ECHO parameters, differences were present among groups in systolic pulmonary arterial pressure (sPAP) and left ventricle end-systolic diameter (LVEF) (p < 0.001 and 0.004, respectively). sPAP was highest in groups D and B whereas LVEF was lowest in group D. Conclusion: Our results suggest that patients’ symptoms in symptomatic COPD groups B and D might be related to increased PAP and concomitant cardiovascular comorbidities. Therefore, a detailed cardiovascular investigation should be performed from early stages in COPD.
Comparative Long-term Effects of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Real-life Study with Five-year Follow-up - Thoracic Research and Practice